Kengo Sakaguchi
Noda, 2788510, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
A silyl porphyrin derivative conjugated with 6-deoxy-6-sulfo-α-d-glucopyranose functions as an efficient photosensitizer for photodynamic therapy.
Journal: Photodiagnosis and photodynamic therapy
Published: August 24, 2023
The natural sulfoglycolipid derivative SQAP improves the therapeutic efficacy of tissue factor-targeted radioimmunotherapy in the stroma-rich pancreatic cancer model BxPC-3.
Journal: Translational oncology
Published: August 03, 2021
Synthesis of 3-octadecanoxypropyl 6-deoxy-6-sulfo-α-d-glucopyranoside (ODSG) as a lipase-resistant SQAP derivative.
Journal: Bioorganic & medicinal chemistry letters
Published: July 08, 2021
Epo-C12 inhibits peroxiredoxin 1 peroxidase activity.
Journal: Bioorganic & medicinal chemistry
Published: March 31, 2021
Phage display technology for target determination of small-molecule therapeutics: an update.
Journal: Expert opinion on drug discovery
Published: July 15, 2020
SQAP, an acyl sulfoquinovosyl derivative, suppresses expression of histone deacetylase and induces cell death of cancer cells under hypoxic conditions.
Journal: Bioscience, biotechnology, and biochemistry
Published: May 13, 2020
Using the QCM Biosensor-Based T7 Phage Display Combined with Bioinformatics Analysis for Target Identification of Bioactive Small Molecule.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: May 31, 2018
A Multimodal Molecular Imaging Study Evaluates Pharmacological Alteration of the Tumor Microenvironment to Improve Radiation Response.
Journal: Cancer research
Published: May 31, 2018
Distribution and metabolism of 14C-sulfoquinovosylacylpropanediol (14C-SQAP) after a single intravenous administration in tumor-bearing mice.
Journal: Xenobiotica; the fate of foreign compounds in biological systems
Published: March 16, 2018
Novel anticancer agent, SQAP, binds to focal adhesion kinase and modulates its activity.
Journal: Scientific reports
Published: May 27, 2015
Sulfoquinovosylacylpropanediol is a novel potent radiosensitizer in prostate cancer.
Journal: International journal of urology : official journal of the Japanese Urological Association
Published: November 22, 2014
Last Updated: 09/26/2026